Local view for "http://purl.org/linkedpolitics/eu/plenary/2012-09-10-Speech-1-234-000"

Predicate	Value (sorted: default)
rdf:type	lpv_eu:Speech2
dcterms:Date	"2012-09-10"^^xsd:date2
dcterms:Is Part Of	lp_eu:Pharmacovigilance (amendment of Directive 2001/83/EC) - Pharmacovigilance (amendment of Regulation (EC) No 726/2004) (debate)2
dcterms:Language	"de"^^xsd:language2
lpv:document identification number	"en.20120910.29.1-234-000"2
lpv:hasSubsequent	lp_eu:2012-09-10-Speech-1-235-0002
lpv:speaker	lp:Franz Obermayr2
lpv:spokenAs	member; Delegation for relations with the Mashreq countries (2012-02-13--2014-06-30)3 substitute; EMPL (2012-01-19--2014-06-30)3 member; IMCO (2012-01-19--2014-06-30)3 member; Delegation to the Parliamentary Assembly of the Union for the Mediterranean (2012-03-29--2014-06-30)3 substitute; Delegation to the EU-Kazakhstan, EU-Kyrgyzstan and EU-Uzbekistan Parliamentary Cooperation Committees, and for relations with Tajikistan, Turkmenistan and Mongolia (2009-09-16--2014-06-30)3 unknown; Freiheitliche Partei Österreichs (2009-07-14--2014-06-30)3 member; NA (2009-07-14--2014-06-30)3
lpv:translated text	"Madam President, it is absolutely necessary that we should continue to monitor medicines after their marketing authorisation, the more so given that they are only trialled on a relatively small number of patients. New knowledge often only comes to light once the medicine in question is already on the market. Medicinal products that require additional monitoring or are subject to a post-authorisation safety study (PASS) should be labelled to that effect using a black symbol. In addition, doctors, patients and the authorities must be told in good time – meaning as soon as possible – when and why a medicinal product that had, up to then, been regarded as safe is withdrawn from the market. Clearly, we cannot allow a situation where investors in pharmaceutical companies are informed before doctors and pharmacists. Ultimately, the monitoring of medicinal products, as good as it is, only serves patients if it warns them in good time of a dangerous medicine."@en1
lpv:videoURI	<go to Events_and_structure europarl>2

Named graphs describing this resource:

The resource appears as object in 2 triples

Context graph